We write to report on the Association of Children’s Diabetes Clinicians’ (ACDC) national survey on access to continuous glucose monitoring (CGM) and Freestyle Libre Flash Glucose Sensors (FGS) for children and young people (CYP) with type 1 diabetes (T1DM) in England and Wales. CGM and FGS allow continuous blood glucose monitoring for patients with T1DM, therefore reducing the need for finger-prick blood testing. CGM provides a continuous interstitial glucose reading, whereas FGS requires 8 hourly scans to provide data with no alarms. Funding pathways for such devices are complex. While there is clear guidance from The National Institute of Health and Care Excellence (NICE) with regards to whom CGM should be prescribed,1 access is determined locally by Clinical Commissioning Groups (CCGs). Some CCGs require individual funding applications (IFAs), whereas others have local policies on who should access devices. The recently published National Health Service (NHS) Long-Term Plan, advises that all individuals meeting published clinical criteria should be able to access FGS devices from April …